About this Journal Submit a Manuscript Table of Contents
AIDS Research and Treatment
Volume 2012 (2012), Article ID 317695, 8 pages
http://dx.doi.org/10.1155/2012/317695
Research Article

Evaluation of Hepatic Mitochondria and Hematological Parameters in Zidovudine-Treated Mice

1Division of Systems Biology, Center for Functional Genomics, U.S. FDA/National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079, USA
2Department of Information and Mathematics, Korea University, Jochiwon, Chungnam 339-700, Republic of Korea
3Division of Genetic and Molecular Toxicology, U.S. FDA/National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079, USA
4Office of Scientific Coordination, U.S. FDA/National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079, USA

Received 28 November 2011; Accepted 12 January 2012

Academic Editor: Robert R. Redfield

Copyright © 2012 Varsha G. Desai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The effects of 12-week exposure to zidovudine (AZT) at 400, 500, and 600 mg/kg/d were examined on expression of 542 mitochondria-related genes and mitochondrial DNA (mtDNA) copy number in the liver of male and female B6C3F1 mice to understand mitochondrial role in sex-related differences in development of lactic acidosis. Plasma lactate levels and hematologic parameters were also examined. Results indicated increased red blood cell (RBC) count in vehicle-treated controls, whereas a dose-related decline in the RBC count was noted in AZT-treated mice compared to the basal levels before treatments began. These decreases were associated with significant dose-related increases in mean corpuscular volume and mean corpuscular hemoglobin levels. This effect was greater in AZT-treated females compared to males. In both sexes, 12-week AZT or vehicle exposure significantly reduced plasma lactate levels compared to the basal levels. Results also showed modest, but significant, changes in the expression of genes associated with apoptosis and lipid metabolism at 600 mg/kg/d AZT. Neither drug nor sex influenced hepatic mtDNA copy number. Altogether, 12-week AZT exposure as high as 600 mg/kg/d did not impair hepatic mitochondria or induce lactic acidosis in B6C3F1 mice. However, AZT-mediated hematologic toxicity appeared to be greater in females compared to males.